Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple-negative breast cancer
Twist1 accelerates tumour vasculogenic mimicry by inhibiting Claudin15 expression in triple-negative breast cancer
复制标题
Twist1通过抑制三阴性乳腺癌中Claudin15的表达来加速肿瘤血管生成拟态
DOI:
10.1111/jcmm.15167
复制
发表时间:
2020
影响因子:
5.3
通讯作者:
Zheng Xu
中科院分区:
文献类型:
--
作者:
Zhang Danfang;Sun Baocun;Zhao Xiulan;Sun Huizhi;An Jindan;Lin Xian;Zhu Dongwang;Zhao Xueming;Wang Xudong;Liu Fang;Zhang Yanhui;Liu Jiameng;Gu Qiang;Dong Xueyi;Qiu Zhiqiang;Liu Zhiyong;Qi Hong;Che Na;Li Jing;Cheng Runfen;Zheng Xu
The up‐regulation of EMT regulator Twist1 has been implicated in vasculogenic mimicry (VM) formation in human triple‐negative breast cancer (TNBC). Twist1 targets the Claudin15 promoter in hepatocellular carcinoma cells. Claudin family members are related with TNBC. However, the relationship between Claudin15 and VM formation is not clear. In this study, we first found that Claudin15 expression was frequently down‐regulated in human TNBC, and Claudin15 down‐regulation was significantly associated with VM and Twist1 nuclear expression. Claudin15 down‐regulation correlated with shorter survival compared with high levels. Claudin15 silence significantly enhanced cell motility, invasiveness and VM formation in the non‐TNBC MCF‐7 cells. Conversely, an up‐regulation of Claudin15 remarkably reduced TNBC MDA‐MB‐231 cell migration, invasion and VM formation. We also showed that down‐regulation of Claudin15 was Twist1‐dependent, and Twist1 repressed Claudin15 promoter activity. Furthermore, GeneChip analyses of mammary glands of Claudin15‐deficient mice indicated that Claudin18 and Jun might be downstream factors of Twist1‐Claudin15. Our results suggest that Twist1 induced VM through Claudin15 suppression in TNBC, and Twist1 inhibition of Claudin15 might involve Claudin18 and Jun expression.